0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
This Week in JAMA |

This Week in JAMA FREE

JAMA. 2005;293(9):1033. doi:10.1001/jama.293.9.1033.
Text Size: A A A
Published online

PROTECTING THE DISTAL MICROCIRCULATION DURING PCI

During percutaneous coronary intervention (PCI) in acute myocardial infarction, embolization of atheromatous and thrombotic debris is common and is thought to compromise patient outcomes. Stone and colleaguesArticle report results of a clinical trial in which patients with ST-segment elevation myocardial infarction and eligible for PCI were randomly assigned to receive either PCI with a distal balloon occlusion and aspiration device to remove embolic debris or PCI without the aspiration device. The authors found the distal protection aspiration system effectively removed embolic debris but did not improve postprocedure coronary flow, time to ST-segment resolution, infarct size, or event-free survival. In an editorial,Article Schömig and Kastrati discuss possible reasons use of the distal protection device failed to yield clinical benefit.

AGE AND SURVIVAL AFTER BREAST CANCER CHEMOTHERAPY

Adjuvant chemotherapy has improved survival in women 50 to 69 years of age with lymph node–positive breast cancer. However, whether women aged 70 years or older may experience similar benefit is not clear. Muss and colleaguesArticle analyzed data from 4 treatment trials of adjuvant chemotherapy for node-positive disease and compared disease-free and overall survival and treatment-related mortality among women of different ages. They found chemotherapy reduced breast cancer mortality and recurrence for all women and found no association between age and disease-free survival. Non–breast cancer–related causes resulted in lower overall survival for women older than 65 years. Treatment-related deaths were few (0.5%) but increased with advancing age. In an editorial,Article Gradishar and Kaklamani discuss factors to consider when treating elderly women with breast cancer.

REDUCING HIP FRACTURES IN STROKE PATIENTS

Patients with a history of stroke are at increased risk of hip fracture and some studies have suggested an association of elevated homocysteine level and increased fracture risk. Sato and colleaguesArticle investigated whether treatment with folate and vitamin B12 would reduce the incidence of hip fractures in elderly Japanese patients with hemiplegia after ischemic stroke. Through 2 years of follow-up, they found a significant reduction in hip fractures in patients receiving folate and vitamin B12 compared with those receiving placebo. In an editorial,Article van Meurs and Uitterlinden discuss potential physiologic mechanisms for the treatment effect observed.

TREATMENT PREFERENCE AND CLINICAL TRIAL OUTCOMES

Randomized clinical trial enrollment may be hampered when patient or physician preference for treatment leads to refusal of randomization. King and colleagues reviewed data from 32 randomized clinical trials to assess whether patient or physician preference affects trial recruitment or outcomes. They found that patient treatment preferences did lead to refusals of randomization, but there was scant evidence that treatment preference significantly affects the validity of trial outcomes.

See Article

LEARNING EMPATHY

Evidence supports empathy as an important component of effective medical care, but empathic patient-physician relationships are not universal. In a discussion of empathy in clinical medicine, Larson and Yao equate empathy to “emotional labor” and propose the use of acting methods to help physicians learn and practice empathy.

See Article

MEDICAL NEWS & PERSPECTIVES

A new recipe for growing motor neurons from human embryonic stem cells is expected to help provide insights into such motor neuronal disorders as amyotrophic lateral sclerosis and clues to human stem cell development.

Graphic Jump LocationImage not available.

(Photo credit: Su-Chun Zhang/University of Wisconsin)

See Article

CLINICIAN’S CORNER

Clinical Crossroads
Ms P is a 44-year-old woman with morbid obesity who was recently diagnosed with kidney stones. Curhan discusses the pathophysiology, diagnosis, treatment, and prevention of kidney stones, including particular considerations in obese patients.

See Article

JAMA PEER REVIEWERS

Sincere appreciation is extended to the peer reviewers for JAMA in 2004.

See Article and Article

JAMA PATIENT PAGE

For your patients: Information about kidney stones.

See Article

Figures

Graphic Jump LocationImage not available.

(Photo credit: Su-Chun Zhang/University of Wisconsin)

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...